QTRILMET Trademark

Trademark Overview

On Friday, September 4, 2015, a trademark application was filed for QTRILMET with the United States Patent and Trademark Office. The USPTO has given the QTRILMET trademark a serial number of 86747763. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 29, 2023. This trademark is owned by AstraZeneca AB. The QTRILMET trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation
qtrilmet

General Information

Serial Number86747763
Word MarkQTRILMET
Filing DateFriday, September 4, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 29, 2023
Registration Number5158767
Registration DateTuesday, March 14, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 21, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 29, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Friday, September 29, 2023CANCELLED SEC. 8 (6-YR)
Monday, March 14, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 14, 2017REGISTERED-PRINCIPAL REGISTER
Monday, February 6, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, January 25, 2017NOTICE OF ALLOWANCE CANCELLED
Friday, February 3, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 25, 2017TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, August 16, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 21, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 1, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 17, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 10, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 10, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 10, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 6, 2016ASSIGNED TO LIE
Monday, April 25, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 16, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 16, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 11, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 11, 2015NON-FINAL ACTION E-MAILED
Friday, December 11, 2015NON-FINAL ACTION WRITTEN
Thursday, December 10, 2015ASSIGNED TO EXAMINER
Wednesday, September 9, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 8, 2015NEW APPLICATION ENTERED

Related Keywords

qtrilmet diseases disorders substances preparations pharmaceutical nervous system inflammation infection gastrointestinal